Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic...

por Shinozaki, Eiji, Yoshino, Takayuki, Tsuchihara, Katsuya
Publicado 2018

Critical Role of H(2)O(2) Generated by NOX4 during Cellular Response under Glucose Deprivation

por Owada, Satoshi, Shimoda, Yuko, Tsuchihara, Katsuya, Esumi, Hiroyasu
Publicado 2013

Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines

por Nasuno, Tomomitsu, Mimaki, Sachiyo, Okamoto, Makito, Esumi, Hiroyasu, Tsuchihara, Katsuya
Publicado 2014

Classification and characterization of alternative promoters in 26 lung adenocarcinoma cell lines

por Hamaya, Yamato, Suzuki, Ayako, Suzuki, Yutaka, Tsuchihara, Katsuya, Yamashita, Riu
Publicado 2022

Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma

por Makinoshima, Hideki, Takita, Masahiro, Matsumoto, Shingo, Yagishita, Atsushi, Owada, Satoshi, Esumi, Hiroyasu, Tsuchihara, Katsuya
Publicado 2014

Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment

por Suzuki, Ayako, Matsushima, Koutatsu, Makinoshima, Hideki, Sugano, Sumio, Kohno, Takashi, Tsuchihara, Katsuya, Suzuki, Yutaka
Publicado 2015

PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation

por Kageyama, Shun-ichiro, Junyan, Du, Hojo, Hidehiro, Motegi, Atsushi, Nakamura, Masaki, Tsuchihara, Katsuya, Akimoto, Tetsuo
Publicado 2020

Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines

por Suzuki, Ayako, Makinoshima, Hideki, Wakaguri, Hiroyuki, Esumi, Hiroyasu, Sugano, Sumio, Kohno, Takashi, Tsuchihara, Katsuya, Suzuki, Yutaka
Publicado 2014

DBTSS as an integrative platform for transcriptome, epigenome and genome sequence variation data

por Suzuki, Ayako, Wakaguri, Hiroyuki, Yamashita, Riu, Kawano, Shin, Tsuchihara, Katsuya, Sugano, Sumio, Suzuki, Yutaka, Nakai, Kenta
Publicado 2014

Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines

por Sereewattanawoot, Sarun, Suzuki, Ayako, Seki, Masahide, Sakamoto, Yoshitaka, Kohno, Takashi, Sugano, Sumio, Tsuchihara, Katsuya, Suzuki, Yutaka
Publicado 2018

SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors

por Nakamura, Yoshiaki, Fujisawa, Takao, Taniguchi, Hiroya, Bando, Hideaki, Okamoto, Wataru, Tsuchihara, Katsuya, Yoshino, Takayuki, Ohtsu, Atsushi
Publicado 2021

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal

por You, Han, Pellegrini, Marc, Tsuchihara, Katsuya, Yamamoto, Kazuo, Hacker, Georg, Erlacher, Miriam, Villunger, Andreas, Mak, Tak W.
Publicado 2006

Correction: FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal

por You, Han, Pellegrini, Marc, Tsuchihara, Katsuya, Yamamoto, Kazuo, Hacker, Georg, Erlacher, Miriam, Villunger, Andreas, Mak, Tak W.
Publicado 2021

Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak

por Hojo, Hidehiro, Dohmae, Takeshi, Hotta, Kenji, Kohno, Ryosuke, Motegi, Atsushi, Yagishita, Atsushi, Makinoshima, Hideki, Tsuchihara, Katsuya, Akimoto, Tetsuo
Publicado 2017

Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11

por Taniguchi, Hiroya, Yamazaki, Kentaro, Yoshino, Takayuki, Muro, Kei, Yatabe, Yasushi, Watanabe, Toshiaki, Ebi, Hiromichi, Ochiai, Atsushi, Baba, Eishi, Tsuchihara, Katsuya
Publicado 2015

Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer

por Suzuki, Ayako, Suzuki, Mizuto, Mizushima-Sugano, Junko, Frith, Martin C, Makałowski, Wojciech, Kohno, Takashi, Sugano, Sumio, Tsuchihara, Katsuya, Suzuki, Yutaka
Publicado 2017

Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer

por Fujioka, Rumi, Mochizuki, Nobuo, Ikeda, Masafumi, Sato, Akihiro, Nomura, Shogo, Owada, Satoshi, Yomoda, Satoshi, Tsuchihara, Katsuya, Kishino, Satoshi, Esumi, Hiroyasu
Publicado 2018

Characterization of cancer omics and drug perturbations in panels of lung cancer cells

por Suzuki, Ayako, Onodera, Keiichi, Matsui, Ken, Seki, Masahide, Esumi, Hiroyasu, Soga, Tomoyoshi, Sugano, Sumio, Kohno, Takashi, Suzuki, Yutaka, Tsuchihara, Katsuya
Publicado 2019

Identification and Characterization of Cancer Mutations in Japanese Lung Adenocarcinoma without Sequencing of Normal Tissue Counterparts

por Suzuki, Ayako, Mimaki, Sachiyo, Yamane, Yuki, Kawase, Akikazu, Matsushima, Koutatsu, Suzuki, Makito, Goto, Koichi, Sugano, Sumio, Esumi, Hiroyasu, Suzuki, Yutaka, Tsuchihara, Katsuya
Publicado 2013

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition

por Yamazaki, Kentaro, Taniguchi, Hiroya, Yoshino, Takayuki, Akagi, Kiwamu, Ishida, Hideyuki, Ebi, Hiromichi, Nakatani, Kaname, Muro, Kei, Yatabe, Yasushi, Yamaguchi, Kensei, Tsuchihara, Katsuya
Publicado 2018